At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 61 enrolled
Drug / intervention
Pregabalin +1 moredrug
Likely dose
Pregabalin 300 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Placebo-Controlled Study of Whether Pre-operative Pregabalin 300 mg Will Improve Pain Control in Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass (Bariatric Surgery)
In Brief
A Phase 4 clinical trial evaluating Pregabalin and Placebo (for Pregabalin) for Post-operative Pain. Completed, enrolled 61 participants across 1 site.
Detailed Summary
Randomized clinical trial to evaluate whether a single pre-operative dose of Pregabalin will alleviate post-operative pain and decrease post-operative analgesic requirements in morbidly obese patients undergoing laparoscopic gastric bypass surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-operative Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedFeb 2013
Primary CompletionDec 2015
Study CompletionJan 2016
TodayJul 2026
First PostedFeb 28, 2013
Enrollment StartFeb 1, 2013
Primary CompletionDec 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 13.3 years ago
Interventions
Pregabalindrug
One 300 mg oral dose of Pregabalin given before surgery.
Placebo (for Pregabalin)drug
One oral dose of placebo given before surgery.